| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/22/1998 | CA2260214A1 Methods of enhancing lean tissue mass and bone mineral content and compositions therefor |
| 01/22/1998 | CA2260044A1 Novel treatment of leptine resistance |
| 01/21/1998 | EP0819436A2 Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0818956A1 Cereal food product high in soluble fiber |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171050A 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same and use for treating insulin resistance |
| 01/21/1998 | CN1170761A Process for production of lipstatin and tetrahydrolipstatin |
| 01/21/1998 | CN1170716A Di-ortho substituted benzoyl guanidine, its preparing method, use and medicine containing them |
| 01/21/1998 | CN1170600A Pure Chinese drug tangniaojing for curing diabetes |
| 01/21/1998 | CN1170516A Growth promotion feed for chickens and method |
| 01/20/1998 | US5710244 Derivatized calcitonins |
| 01/20/1998 | US5710145 Protein kinase C inhibitor |
| 01/20/1998 | US5710143 Anti-obesity agents |
| 01/20/1998 | US5710035 Human elastase IV |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5709888 High fat nutritional formula for infants and adults |
| 01/20/1998 | US5709864 Cosmetic or pharmaceutical and particularly dermatological, composition containing an extract of tephrosia, particularly Tephrosia purpurea |
| 01/15/1998 | WO1998001426A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/14/1998 | EP0818448A1 Cycloalkano-pyridine as CETP inhibitors |
| 01/14/1998 | EP0818447A1 6-(Hydroxymethyl-ethyl)pyridines as HMG-CoA-reductase inhibitors |
| 01/14/1998 | EP0818197A1 Heterocyclic condensed pyridines as CETP inhibitors |
| 01/14/1998 | EP0818196A1 Food or drink containing dioxabicyclo (3.3.0) octane compounds |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817641A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0783315A4 Hydration compositions for human or animal bodies |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | CN1170411A Quinoline derivative |
| 01/14/1998 | CN1169987A Ortho-substituen benzoyl guanidine, its preparation, use and mecdicines containing it |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708020 Arylalkyl(thio)amides |
| 01/13/1998 | US5707970 Treatment of atheriosclerosis and as nutrients formed by reaction of arginine, silicate salt and inositol |
| 01/13/1998 | US5707854 Lactic acid bacteria of the Genus lactobacillus |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step |
| 01/13/1998 | US5707657 Regenerating, repairing organs |
| 01/13/1998 | US5707609 Graphite bar, petrochemical binder |
| 01/08/1998 | WO1998000403A1 Hypoglycemic and hypolipidemic compounds |
| 01/08/1998 | WO1998000389A1 2-hydroxypropionic acid derivative and its manufacturing method |
| 01/08/1998 | WO1998000130A2 Anticonvulsant sulfamate derivatives useful in treating obesity |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2259431A1 Hypoglycemic and hypolipidemic compounds |
| 01/08/1998 | CA2209609A1 Bicyclic-fused pyridines |
| 01/08/1998 | CA2209550A1 6-(hydroxymethyl-ethyl)pyridines |
| 01/07/1998 | EP0816359A1 4-Amino-2-ureido-pyrimidine-5-carboxamides, processes for their preparation, medicaments containing these compounds, and their use |
| 01/07/1998 | EP0816358A1 4-Amino-2-ureido-pyrimidine-5-carboxamides, processes for their preparation, medicaments containing these compounds, and their use |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0816329A1 Benzoic acid derivatives, process for their preparation and their use for the treatment of diseases |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815224A1 Receptor activation by gas6 |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815212A1 Novel encapsulation process by a gelling polymer |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815136A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815124A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/07/1998 | EP0814842A1 Method for treating amyloidosis |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814799A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis |
| 01/07/1998 | EP0814796A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814788A1 Improving glucose tolerance |
| 01/07/1998 | EP0814786A2 Pinitol and derivatives thereof for the treatment of metabolic disorders |
| 01/07/1998 | EP0814782A1 Pharmaceutical composition stabilized with a basic agent |
| 01/07/1998 | EP0814779A1 Novel encapsulation compositions and methods |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/07/1998 | EP0682529B1 Antibody for the treatment of insulin dependent diabetes |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | CN1169425A Fluorinated vitamin D3 analogs |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705529 N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same |
| 01/06/1998 | US5705528 Farnesyl derivatives and pharmaceutical compositions containing them |
| 01/06/1998 | US5705526 Hypercholesterolemia therapeutic agent |
| 01/06/1998 | US5705515 Having reduced side effects |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705483 Glucagon-like insulinotropic peptides, compositions and methods |
| 01/06/1998 | US5705388 CETP Ribozymes |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049736A2 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049670A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/31/1997 | WO1997049420A1 Lectin compositions and uses thereof |
| 12/31/1997 | WO1997049395A1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049387A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | CA2258851A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2258744A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2252809A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/30/1997 | US5703121 Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound |